일부 농촌 지역 성인에서 C-reactive protein농도와 경동맥 내중막 두께
C-reactive Protein and Carotid Intima-media Thickness in a Population of Middle-aged Koreans
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives : This study was performed to evaluate the relationship between C-reactive protein (CRP) and carotid intima-media thickness (carotid IMT) in a population of middle-aged Koreans. Methods : A total of 1,054 men and 1,595 women (aged 40-70 years) from Kanghwa County, Korea, were chosen for the present study between 2006 and 2007. We measured high-sensitivity CRP and other major cardiovascular risk factors including anthropometrics, blood pressure, blood chemistry, and carotid ultrasonography. Health related questionnaires were also completed by each study participant. Carotid IMT value was determined by the maximal IMT at each common carotid artery. The relationship between CRP level and carotid IMT was assessed using multiple linear and logistic regression models after adjustment for age, body mass index, menopause (women), systolic blood pressure, total/HDL cholesterol ratio, triglyceride level, fasting glucose, smoking, and alcohol consumption. Results : Mean carotid IMT values from the lowest to highest quartile of CRP were 0.828, 0.873, 0.898, and 0.926 mm for women (p for trend<0.001), and 0.929, 0.938, 0.949, and 0.979 mm for men (p for trend=0.032), respectively. After adjustment for major cardiovascular risk factors, the relationship between CRP and carotid IMT was significant in women (p for trend=0.017), but not in men (p for trend=0.798). Similarly, adjusted odds ratio of increased IMT, defined as the sex-specific top quartile, for the highest versus lowest CRP quartiles was 1.55 (95% CI=1.06-2.26) in women, but only 1.05 (95% CI=0.69-1.62) in men. Conclusions : CRP and carotid IMT levels appear to be directly related in women, but not in men.
Abstract
Objectives : This study was performed to evaluate the relationship between C-reactive protein (CRP) and carotid intima-media thickness (carotid IMT) in a population of middle-aged Koreans. Methods : A total of 1,054 men and 1,595 women (aged 40-70 years) from Kanghwa County, Korea, were chosen for the present study between 2006 and 2007. We measured high-sensitivity CRP and other major cardiovascular risk factors including anthropometrics, blood pressure, blood chemistry, and carotid ultrasonography. Health related questionnaires were also completed by each study participant. Carotid IMT value was determined by the maximal IMT at each common carotid artery. The relationship between CRP level and carotid IMT was assessed using multiple linear and logistic regression models after adjustment for age, body mass index, menopause (women), systolic blood pressure, total/HDL cholesterol ratio, triglyceride level, fasting glucose, smoking, and alcohol consumption. Results : Mean carotid IMT values from the lowest to highest quartile of CRP were 0.828, 0.873, 0.898, and 0.926 mm for women (p for trend<0.001), and 0.929, 0.938, 0.949, and 0.979 mm for men (p for trend=0.032), respectively. After adjustment for major cardiovascular risk factors, the relationship between CRP and carotid IMT was significant in women (p for trend=0.017), but not in men (p for trend=0.798). Similarly, adjusted odds ratio of increased IMT, defined as the sex-specific top quartile, for the highest versus lowest CRP quartiles was 1.55 (95% CI=1.06-2.26) in women, but only 1.05 (95% CI=0.69-1.62) in men. Conclusions : CRP and carotid IMT levels appear to be directly related in women, but not in men.
참고문헌 (28)
- Berliner JA, "Athero sclerosis: Basic mechanisms. Oxidation, inflammation, and genetics", Circulation, 91(9), pp.2488~2496 (1995)
- Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", N Engl J Med, 352(16), pp.1685~1695 (2005)
- Rifai N, "High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease", Clin Chem, 47(3), pp.403~411 (2001)
- Ferranti SD, "C-reactive protein: A nontraditional serum marker of cardiovascular risk", Cardiovasc Pathol, 16(1), pp.14~21 (2007)
- Ridker PM, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336(14), pp.973~979 (1997)
- Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", N Engl J Med, 342(12), pp.836~843 (2000)
- Chambless LE, "Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993", Am J Epidemiol, 146(6), pp.483~494 (1997)
- Pearson TA, "Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association", Circulation, 107(3), pp.499~511 (2003)
- Lorenz MW, "High-sensitivity C-reactive protein is not associated with carotid intima-media pro gression: The Carotid Atherosclerosis Progression Study", Stroke, 38(6), pp.1774~1779 (2007)
- Hayaishi-Okano R, "Elevated C-reactive protein associated with early-stage carotid atherosclerosis in young subjects with type 1 diabetes", Diabetes care, 25(8), pp.1432~1438 (2002)
- Sitzer M, "C-reactive protein and carotid intima media thickness in a community population", J Cardiovasc Risk, 9(2), pp.97~103 (2002)
- Thakore AH, "Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study)", Am J Cardiol, 99(11), pp.1598~1602 (2007)
- Elias-Smale SE, "C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; Results from the Rotterdam study", Atherosclerosis, 195(2), pp.e195~e202 (2007)
- Choi SH, "Is high-sensitivity Creactive protein associated with carotic atherosclerosis in healthy Koreans?", Eur J Cardiovasc Prev Rehabil, 12(6), pp.548~554 (2005)
- Ryu So Yeon, "Relations of Plasma High-Sensitivity C-Reactive Protein to Various Cardiovascular Risk Factors", Journal of Korean Medical Science, 20(3), pp.379~383 (2005), 대한의학회
- Chobanian AV, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report", JAMA, 289(19), pp.2560~2572 (2003)
- Expert Panel on Detection, "Executive Summary of The ThirdReport of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)", JAMA, 285(19), pp.2486~2497 (2001)
- World Health Organization Western Pacif, "The Asia-Pacific Perspective: Redefining Obesity and its Treatment" (2000), Health Communications Australia
- Saito I, "A low level of Creactiveprotein in Japanese adults and its association with cardiovascular risk factors: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study", Atherosclerosis, 194(1), pp.238~244 (2007)
- Ridker PM, "Creactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8- year follow-up of 14179 initially healthy American women", Circulation, 107(3), pp.391~397 (2003)
- Wang TJ, "Association of Creactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study", Atheroscler Thromb Vasc Biol, 22(10), pp.1662~1667 (2002)
- 강은석, "제 2형 당뇨병 환자에서 혈청 High Sensitivity C-reactive Protein과 경동맥 내중막두께 및 미세혈관합병증과의 관계", 대한내과학회지, 65(4), pp.443~450 (2003), 대한내과학회
- Song HY, "Realationship between inflammatory markers and high resolution Bmode carotid artery ultrasono-graphy in continuous ambulatory peritoneal dialysis (CAPD) patients", Korean J Nephrol, 21(2), pp.285~294 (2002)
- Son JC, "The most associated risk factor of the metabolic syndrome with C-reactive protein", J Korean Soc Study Obes, 12(1), pp.15~23 (2003)
- Eckel RH, "The metabolic syndrome", Lancet, 365(9468), pp.1415~1428 (2005)
- Timpson NJ, "C-reactive protein and its role in metabolic syndrome: Mendelian randomization study", Lancet, 366(9468), pp.1954~1959 (2005)
- Hotamisiligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance", J Clin Invest, 95(5), pp.2409~2415 (1995)
- Warren RS, "The acute metabolic effects of tumor necrosis factor administration in human", Arch Surg, 122(12), pp.1396~1400 (1987)